News

2 June 2021

2 июня на полях ПМЭФ подписана Декларация о политике в области разработки, производства, ...

27 April 2021

The year 2020 has become one of the most ambitious and significant for Acticomp.

22 April 2021

Acticomp received the main prize of the pharmaceutical industry in the nomination "Project ...

8 April 2021

At the end of March, Acticomp received state registration

19 February 2021

European Union officials have adopted a list of Covid-19 rapid

15 January 2021

The company Acticomp joined the Association of Pharmaceutical Manufacturers of the EAEU

25 December 2020

On December 25, the official opening of the first ...

5 December 2020

St. Petersburg has hosted the awards ceremony of the best industrialists presenting them with honorary badges...

19 November 2020

The document, which was signed by both companies, provides ...

30 October 2020

Domestic manufacturer of active pharmaceutical ingredients (APIs), the company Active ...

22 October 2020

The Ministry of Industry and Trade of the Russian Federation, the Government of St. Petersburg ...

25 June 2020

Acticomp entered into an exclusive agreement with the world leader in the field of in vitro ...

23 May 2019

The conclusion on confirmation of production of industrial output in the territory ...

19 April 2019

The Ministry of Industry and Trade of the Russian Federation together with the State Institute of Medicines and ...

11 April 2019

Alexander Semenov, President of the Active Component Company, at a speech in ...

21 May 2018

Dmitry Medvedev signed the Resolution No. 572 of May 12, 2018, aimed at supporting pharmaceutical manufacturers, all stages of

12 February 2018

  EUROPEAN ENGINEERING COMPANY WILL DEVELOP A PROJECT OF A NEW FACTORY IN ...

5 February 2018

The Active Component company, one of the leaders in the production of active pharmaceutical ...

21 December 2017

JSC “Acticomp” and Pharmkontrakt GC signed an agreement for the

21 November 2017

JSC ACTICOMP TAKES PART IN PHARMTECH & INGREDIENTS INTERNATIONAL EXHIBITION

8 November 2017

PHARMACEUTICAL INDUSTRY IN ST. PETERSBURG EXPERIENCES SME SHORTAGE

26 October 2017

On 26 October, at the New Stage of the Alexandrinsky Theatre

22 September 2017

RUSSIA AND SYRIA PHARMACEUTICAL PRODUCTS SUPPLY MAY START IN MAY 2018

19 September 2017

RUSSIAN PHARMACEUTICAL MARKET NEEDS A DEVELOPMENT PROGRAM FOR AT LEAST 10 YEARS AHEAD

11 September 2017

CJSC “Acticomp”, one of the leading Russian producer of active pharmaceutical substances, and UniCredit Leasing LLC signed an agreement for the acquisition of new equipment.

6 July 2017

Students of Saint Petersburg State Chemical Pharmaceutical Academy visited the production site of “Acticomp” in the village of Metallostroy, which is likely to become

20 June 2017

“Acticomp” completed the modernization of the production site in Metallostroy settlement in the south-east of St. Petersburg. The volume of production of substances

8 June 2017

On 7 June, St. Petersburg hosted a solemn ceremony of awarding the winners of Gazelle Business-2017 annual rating. The rating was introduced by Delovoy Petersburg newspaper and engages the fastest growing companies in the city.

6 June 2017

Alexander Semyonov, President and co-owner of the St.Petersburg company “Acticomp” discussed the issue with Komsomolka newspaper at the SPIEF. The goals of the pharmaceuticals manufacturer are in line with the objectives of the forum. It

18 April 2016

In December 2015, JSC “Acticomp” received a statement on

13 April 2016

Gazprombank Leasing Standard LLC and St.Petersburg manufacturer of pharmaceuticals “Acticomp” signed an agreement under which the plant acquires new equipment in the amount of more than

13 April 2016

This year “Acticomp”, a St. Petersburg-based manufacturer of active pharmaceutical substances (raw materials for the production of medicines), plans to invest 300 million rubles

4 February 2016

https://www.youtube.com/watch?v=JzcY0nWaCLw...

29 April 2015

CJSC “Acticomp” has got a patent for the industrial method of obtaining the crystalline form of IV Tilorone dihydrochloride.

17 March 2015

By the decision of the Ministry of Health of the Russian Federation, the State

17 March 2015

By the decision of the Ministry of Health of the Russian Federation, the State Register of Medicines for Medical Use now includes the substance Troventol produced by CJSC “Acticomp”

10 November 2014

By the decision of the Ministry of Health of the Russian Federation, the State

6 May 2013

By the decision of the Ministry of Health of the Russian Federation, the State Register of Medicines

12 April 2013

CJSC “Acticomp” successfully exhibited at the international exhibition IPHEB & CPHI Russia 2013.

8 February 2013

CJSC “Acticomp” renewed the production license and the license for pharmaceutical activities.

10 December 2012

AKRIKHIN OJSC AUDIT PASSED

19 October 2012

By the decision of the Ministry of Health of the Russian Federation, the State Register of Medicines

1 August 2011

Inna Bakhtina was appointed CEO by the General Meeting of Shareholders of CJSC “Acticomp”

19 April 2011

Stada CIS LLC audit was passed.

16 July 2009

Valenta Pharmacevtika OJSC audit was passed.

20 May 2009

Canonpharma Production CJSC audit was passed.

18 December 2008

18/12/2008 Makiz Pharma CJSC audit was passed.

18 November 2008

Akrikhin OJSC audit was passed.

Visit Us On FacebookVisit Us On Youtube